CN112616314A - (3r,5r)-7-[2-(4-氟苯基)-5-异丙基-3-苯基-4-[(4-羟甲基苯基氨基)羰基]-吡咯-1-基]-3,5-二羟基庚酸半钙盐的制备方法、用于其的中间体及中间体的制备方法 - Google Patents

(3r,5r)-7-[2-(4-氟苯基)-5-异丙基-3-苯基-4-[(4-羟甲基苯基氨基)羰基]-吡咯-1-基]-3,5-二羟基庚酸半钙盐的制备方法、用于其的中间体及中间体的制备方法 Download PDF

Info

Publication number
CN112616314A
CN112616314A CN201980055467.7A CN201980055467A CN112616314A CN 112616314 A CN112616314 A CN 112616314A CN 201980055467 A CN201980055467 A CN 201980055467A CN 112616314 A CN112616314 A CN 112616314A
Authority
CN
China
Prior art keywords
chemical formula
compound
alkyl
formula
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980055467.7A
Other languages
English (en)
Chinese (zh)
Inventor
朴恩婷
李元一
朴相昱
金甫贞
丁藇熙
金澈佑
慎祥允
赵民龙
孙世一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dae Won Pharmaceutical Co ltd
Daewon Pharm Co Ltd
Original Assignee
Dae Won Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Won Pharmaceutical Co ltd filed Critical Dae Won Pharmaceutical Co ltd
Publication of CN112616314A publication Critical patent/CN112616314A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/19Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/76Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201980055467.7A 2018-08-24 2019-08-23 (3r,5r)-7-[2-(4-氟苯基)-5-异丙基-3-苯基-4-[(4-羟甲基苯基氨基)羰基]-吡咯-1-基]-3,5-二羟基庚酸半钙盐的制备方法、用于其的中间体及中间体的制备方法 Pending CN112616314A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2018-0099383 2018-08-24
KR1020180099383A KR102001835B1 (ko) 2018-08-24 2018-08-24 (3r,5r)-7-(2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-((4-히드록시메틸페닐아미노)카보닐)-피롤-1-일)-3,5-디히드록시 헵탄산 헤미칼슘염의 제조방법, 이에 사용되는 중간체, 및 중간체의 제조방법
PCT/KR2019/010799 WO2020040614A1 (ko) 2018-08-24 2019-08-23 (3r,5r)-7-[2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-[(4-히드록시메틸페닐아미노)카보닐]-피롤-1-일]-3,5-디히드록시 헵탄산 헤미칼슘염의 제조방법, 이에 사용되는 중간체, 및 중간체의 제조방법

Publications (1)

Publication Number Publication Date
CN112616314A true CN112616314A (zh) 2021-04-06

Family

ID=67511878

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980055467.7A Pending CN112616314A (zh) 2018-08-24 2019-08-23 (3r,5r)-7-[2-(4-氟苯基)-5-异丙基-3-苯基-4-[(4-羟甲基苯基氨基)羰基]-吡咯-1-基]-3,5-二羟基庚酸半钙盐的制备方法、用于其的中间体及中间体的制备方法

Country Status (3)

Country Link
KR (1) KR102001835B1 (ko)
CN (1) CN112616314A (ko)
WO (1) WO2020040614A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114096523A (zh) * 2019-07-12 2022-02-25 大元制药株式会社 制备(3r,5r)-7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-((4-羟甲基苯基氨基)羰基)-吡咯-1-基)-3,5-二羟基庚酸半钙盐的方法以及制备其所用中间体的方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247633A1 (en) * 1986-05-30 1987-12-02 Warner-Lambert Company Trans-6-[2-(3- or 4-Carboxamido-substituted pyrrol-1-yl)-alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
EP0680963A1 (en) * 1994-05-04 1995-11-08 Warner-Lambert Company (Hydroxyphenylamino)carbonyl pyrroles
WO2007054790A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for preparation of (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
CN1980890A (zh) * 2004-05-31 2007-06-13 兰贝克赛实验室有限公司 阿托伐他汀的制备方法
KR20160117843A (ko) * 2015-03-31 2016-10-11 대원제약주식회사 결정형 및 이의 제조방법
CN106397296A (zh) * 2016-08-29 2017-02-15 江苏阿尔法药业有限公司 一种阿托伐他汀的制备工艺

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0247633A1 (en) * 1986-05-30 1987-12-02 Warner-Lambert Company Trans-6-[2-(3- or 4-Carboxamido-substituted pyrrol-1-yl)-alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
EP0680963A1 (en) * 1994-05-04 1995-11-08 Warner-Lambert Company (Hydroxyphenylamino)carbonyl pyrroles
CN1980890A (zh) * 2004-05-31 2007-06-13 兰贝克赛实验室有限公司 阿托伐他汀的制备方法
WO2007054790A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for preparation of (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
KR20160117843A (ko) * 2015-03-31 2016-10-11 대원제약주식회사 결정형 및 이의 제조방법
CN106397296A (zh) * 2016-08-29 2017-02-15 江苏阿尔法药业有限公司 一种阿托伐他汀的制备工艺

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114096523A (zh) * 2019-07-12 2022-02-25 大元制药株式会社 制备(3r,5r)-7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-((4-羟甲基苯基氨基)羰基)-吡咯-1-基)-3,5-二羟基庚酸半钙盐的方法以及制备其所用中间体的方法

Also Published As

Publication number Publication date
KR102001835B1 (ko) 2019-07-19
WO2020040614A1 (ko) 2020-02-27

Similar Documents

Publication Publication Date Title
KR101961897B1 (ko) 사큐비톨의 제조방법
ES2367976T3 (es) Procedimiento para la preparación de sildenafilo.
EP2072503B1 (en) Process for the preparation of bosentan
KR20180012788A (ko) 브리바라세탐의 제조 방법
JP5673729B2 (ja) 4−置換又は非置換テトラヒドロピラン−4−カルボン酸化合物又はそのエステル化合物の製法
AU765286B2 (en) Synthesis of acyclic nucleoside derivatives
JP2018506541A (ja) Nep阻害剤を調製するための方法および中間体
CN112616314A (zh) (3r,5r)-7-[2-(4-氟苯基)-5-异丙基-3-苯基-4-[(4-羟甲基苯基氨基)羰基]-吡咯-1-基]-3,5-二羟基庚酸半钙盐的制备方法、用于其的中间体及中间体的制备方法
CA2016343C (en) Preparation of diazabicyclic intermediates
US11370807B2 (en) Process for preparing sulfonamide compounds
WO2010097802A2 (en) A process for the preparation of etoricoxib
CN109963835B (zh) 一种新毒素及其中间体的制备方法
AU2009311846B2 (en) Method for preparing (3S,4S)-4-((R)-2-(benzyloxy)tridecyl)-3-hexyl-2-oxetanone and novel intermediate used therefor
CN113024489A (zh) 一种奥司他韦合成工艺杂质的制备方法
US9359333B2 (en) Efficient process for the preparation of Lapatinib and salts thereof by means of new intermediates
KR20170078033A (ko) 신규한 스타틴 중간체, 이의 제조방법 및 이를 이용한 로수바스타틴의 제조방법
JP3031279B2 (ja) 2−アルコキシ−6−(トリフルオロメチル)ピリミジン−4−オルの製造方法
KR102441327B1 (ko) 다이아미노피리미딘 유도체 또는 이의 산부가염의 신규의 제조방법
KR102060318B1 (ko) 신규의 중간체, 이의 제조방법, 및 이를 이용한 로수바스타틴 칼슘염의 제조방법
KR100856133B1 (ko) 아토르바스타틴의 개선된 제조방법
JPWO2005058859A1 (ja) 3−(4−テトラヒドロピラニル)−3−オキソプロパン酸アルキル化合物及び4−アシルテトラヒドロピランの製法
KR20160126700A (ko) 스타틴의 중간체, 이의 제조방법 및 이를 이용한 로수바스타틴의 제조방법
Marek et al. Synthesis of Diastereomerically Pure [1, 3] Thiazolo [3, 2-a] azepane Derivatives from D-Hexoses
SU671726A3 (ru) Способ получени 4-а-арил-транс-декагидро-изохинолинов
CN117164526A (zh) 2-(哌嗪-2-基)乙腈类衍生物及其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210406

WD01 Invention patent application deemed withdrawn after publication